# Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma

> **NCT01375972** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 92 (actual)

## Conditions studied

- Metastatic Biliary Cancer

## Interventions

- **DRUG:** S-1 plus cisplatin
- **DRUG:** Gemcitabine plus Cisplatin

## Key facts

- **NCT ID:** NCT01375972
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2011-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01375972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01375972, "Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01375972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*